Home › Funds › CHOREO, LLC › JNJ

CHOREO, LLC position in JNJ

JOHNSON & JOHNSON · Health Care

CHOREO, LLC reported holding 142,622 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$37.8M, representing 0.39% of its reported portfolio and ranking #47 among its reported holdings. CHOREO, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)142.62K sh
Reported value held$37.76M
Portfolio Weight0.39%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CHOREO, LLC's JNJ position evolved

CHOREO, LLC first disclosed a stake in JNJ in Q3 2023 at 40,289 shares (US$6.3M). The position peaked in Q3 2026 at 142,622 shares, worth US$37.8M. Across 13 filings, CHOREO, LLC increased the stake 9 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 142,622 shares valued at US$37.8M — an increase of 2,052 shares quarter over quarter.. Notable position changes include a 36% increase in Q4 2023 (shares rose 1% over the following quarter), a 106% increase in Q2 2024 (shares rose 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 40.29K $6.28M New
Q4 2023 54.65K $8.57M Add
Q1 2024 53.28K $8.43M Reduce
Q2 2024 109.79K $16.07M Add
Q3 2024 114.96K $18.62M Add
Q4 2024 129.58K $18.64M Add
Q1 2025 134.41K $22.29M Add
Q2 2025 139.82K $21.36M Add
Q3 2025 141.72K $26.28M Add
Q4 2025 139.48K $28.86M Reduce
Q1 2026 142.65K $34.87M Add
Q2 2026 140.57K $35.70M Reduce
Q3 2026 142.62K $37.76M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has CHOREO, LLC held JNJ?

CHOREO, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CHOREO, LLC's current position in JNJ?

As of Q3 2026, CHOREO, LLC holds 142.62K shares of JNJ (JOHNSON & JOHNSON), valued at $37.76M, representing 0.39% of its reported portfolio and ranking #47.

Has CHOREO, LLC been buying or selling JNJ?

In the latest 13F filing (Q3 2026), CHOREO, LLC increased its position in JNJ. The position peaked in Q3 2026 at 142.62K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.